MesoTRAP: A Study Comparing Video-assisted Thoracoscopic Partial Pleurectomy/Decortication With I… (NCT03412357) | Clinical Trial Compass
CompletedNot Applicable
MesoTRAP: A Study Comparing Video-assisted Thoracoscopic Partial Pleurectomy/Decortication With Indwelling Pleural Catheter in Patients With Trapped Lung Due to Malignant Pleural Mesothelioma.
United Kingdom23 participantsStarted 2017-08-10
Plain-language summary
Malignant pleural mesothelioma is a cancer, caused by asbestos, which currently affects 2500 people in the UK each year. The main symptom is breathlessness caused by fluid building up in the space between the lung and the chest wall (pleural effusion). Treatment involves draining the fluid to allow the lung to re-expand (pleurodesis). However, sometimes tumour growth over the surface of the lung can prevent it from re-expanding. This 'trapped' lung results in fluid re-accumulation and repeated drainage which can lead to discomfort and multiple hospital visits.
One approach to dealing with 'trapped' lung in mesothelioma is to insert a thin tube (Indwelling Pleural Catheter - IPC) into the space around the lung. The tube can stay in place for a long time allowing patients to drain off fluid at home.
Another approach is a keyhole surgical operation (video-assisted thoracoscopic partial pleurectomy/decortication - VAT-PD) to remove as much tumour as possible from the lining of the lung to allow it to re-expand.
While both approaches are currently offered in clinical practice, it is not known which of the two is most effective at relieving breathlessness. The only way to find out is to conduct a research trial comparing the two. The Investigators plan to do this, but first of all need to carry out a small pilot study to collect information necessary to help plan the full study.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Pathologically confirmed MPM
✓. Trapped lung, defined as a 'clinically significant trapped lung requiring intervention in the opinion of the clinical team"
✓. Considered by the clinical team to be suitable and fit enough to undergo VAT-PD
✓. Community services or patient/carer able to drain IPC at least twice weekly
✓. Considered by the clinical team to be equally suitable for treatment with VAT-PD or IPC, and therefore eligible for treatment allocation by randomisation.
✓. Patient willing to receive either VAT-PD or IPC and attend the respective designated centre for their treatment
✓. Expected survival of at least 4 months, as assessed by managing clinician
Exclusion criteria
✕. Lung re-expands fully following pleural fluid drainage i.e. no entrapment
What they're measuring
1
To measure the standard deviation of Visual Analogue Scale scores for breathlessness